Watch us on YouTube Live at 8:30AM EST
Docusign Inc – Electronic signature platform DocuSign fell as much as 32.5% in pre-market trade Friday, after the company reported earnings the previous day that beat expectations, but issued downbeat fourth-quarter guidance. In its fiscal third quarter earnings, DocuSign said it expects fourth-quarter revenue of $557-563 million, below analyst expectations for $573.8 million. The company reported a 42% year-on-year increase in total revenue of $545.5 million, marking six straight quarters of growth.
Didi Global – Didi Global said it would commence the process of removing its stock from the New York Stock Exchange for a listing in Hong Kong, as China’s dominant ride-hailing service operator makes an unprecedented exit from the world’s largest capital market five months after Chinese regulators opened a probe into the company.
Marvell Technology – Easily topped estimates with EPS, revenue numbers and guidance in its latest report. The chip maker reported a third-quarter loss of $62.5 million, or 8 cents a share, compared with $22.9 million, or 3 cents a share, in the year-ago period. Adjusted earnings, which exclude stock-based compensation expenses and other items, were 43 cents a share, compared with 25 cents a share in the year-ago period. Revenue rose to $1.21 billion from $750.1 million in the year-ago quarter. Analysts forecast a 38 cent/share loss on revenue of $1.15 billion. Marvell forecast adjusted earnings of 45 cents to 51 cents a share on revenue of $1.28 billion to $1.36 billion for the fourth quarter.
Nvidia Corp – Back on watch trading lower after yesterday’s announcement that the U.S. Federal Trade Commission sued to block NVDA’s $80 bln planned acquisition of British chip technology provider Arm on Thursday, the federal body says the deal would allow NVDA control over computing technology and designs that competitors rely on to develop their own competing chips.
Asana Inc – Lower on an earnings miss, the company reported a quarterly adjusted loss of 23 cents per share for the quarter ended in October. The mean expectation of eleven analysts for the quarter was for a loss of 27 cents per share. Revenue rose 352.4% to $266.49 million from a year ago; analysts expected $93.86 million. Asana Inc’s reported EPS for the quarter was a loss of 37 cents. The mean earnings estimate of analysts had fallen by about 0.8% in the last three months.
Moderna Inc – Vaccine makers are higher premarket after back to back negative sessions, the WSJ is reporting The U.S. Food and Drug Administration is setting up guidelines to expedite reviews of COVID-19 vaccines and drugs targeting the Omicron variant. The report suggested companies working on Omicron-tailored vaccines would be expected to meet standards similar to those required for authorization of boosters.
Longeveron Inc – The popular low float name is higher after FDA granted orphan designation to Lomecel-B, its allogeneic bone marrow-derived mesenchymal stromal cells, or MSCs, as a treatment of Hypoplastic Left Heart Syndrome.
Ardelyx Inc – Active again premarket on volume, after the company on Wednesday announced plans to launch IBS-C treatment.
Grab Holdings – Trading higher in its second day following its SPAC merger with Altimeter Growth. Southeast Asia’s largest ride-hailing and delivery firm tumbled sharply in its debut falling more than 40% at its lows.